Integumen Plc, a personal health care company, develops and commercializes a range of products for oral, skin, and wound care markets. The company develops TS1, a disposable tongue vacuum cleaner for professional use in the dental surgery, a tongue gel, and a handle, which turns the tongue vacuum cleaner into a tongue scraper for home use. It also offers Labskin, a 3-dimensional human skin equivalent model for basic and applied skin research, pre-clinical screening, microbial testing, and efficacy studies of personal care products. In addition, the company provides a range of cosmetic skincare products under the Stoer brand; consumer and professional cosmeceutical products under the Visible Youth brand for anti-ageing; and Clarogel, an over-the-counter cosmetic product for the treatment of blemishes. In addition, it offers Wound pHase, a diagnostic tool, which is used in the acidity/alkalinity of the wound; and hydrogel as a dressing for use in the treatment of burns. The company was incorporated in 2016 and is headquartered in Dalkey, Ireland.
Industry, Sector and Symbol
Industry Household & Personal Products
Sub-IndustryN/A
SectorN/A
CIKN/A
Phone+353-1-5373269
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£263,000.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Integumen (LON:SKIN) Frequently Asked Questions
What is Integumen's stock symbol?
Integumen trades on the London Stock Exchange (LON) under the ticker symbol "SKIN."
Has Integumen been receiving favorable news coverage?
Headlines about SKIN stock have trended positive this week, according to InfoTrie. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Integumen earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
Who are some of Integumen's key competitors?
Some companies that are related to Integumen include BOD Australia (BDA), Orchids Paper Products (TIS), Beiersdorf (BDRFF), Biologix Hair (BLGX), Dogness International (DOGZ), ESSITY AKTIEBOL/S (ESSYY), Henkel AG & Co KGaA (HEN3), HENKEL AG & CO/S (HENOY), Joey New York (JOEY), Kimberly Parry Organics (KPOC), L'Oreal (OR) and Radiant Creations Group (RCGP).
What other stocks do shareholders of Integumen own?
Who are Integumen's key executives?
Integumen's management team includes the folowing people:
- Mr. Christopher Bell, CFO, Company Sec. & Exec. Director
- Mr. Donald Nicholson, Exec. Director (Age 61)
- Mr. Gerard James Brandon, CEO & Director (Age 57)
- Mr. Camillus Gerard Glover, COO & Director (Age 58)
- Alex Chapman, Head of Labskin Operations
How do I buy shares of Integumen?
Shares of SKIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Integumen's stock price today?
One share of SKIN stock can currently be purchased for approximately GBX 1.53.
How big of a company is Integumen?
Integumen has a market capitalization of £7.27 million and generates £263,000.00 in revenue each year.
What is Integumen's official website?
How can I contact Integumen?
Integumen's mailing address is Dalkey, 19 Railway Road, DUBLIN, YO41 1LZ, Ireland. The company can be reached via phone at +353-1-5373269.
MarketBeat Community Rating for Integumen (LON SKIN)
MarketBeat's community ratings are surveys of what our community members think about Integumen and other stocks. Vote "Outperform" if you believe SKIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SKIN will underperform the S&P 500 over the long term. You may vote once every thirty days.
